FDA approval for Siemens PET Scan - MRI combo

June 13, 2011 by Deborah Braconnier in Cancer report

(Medical Xpress) -- The Siemens Biograph mMR system, offering both a PET scan and an MRI that work simultaneously, has been given approval by the FDA. The idea behind this machine and the ability to run both tests at the same time is expected to save diagnostic time as well as reduce a patient’s exposure to radiation.

A PET scan, or positron emission tomography, is a medical imaging test which creates three-dimensional images of functioning systems in the . The looks at gamma rays which are emitted by a positron-emitting radionuclide, or tracer, which is placed into the body. They have routinely been paired with CT scans.

An MRI, or magnetic resonance imaging, is a medical imaging that uses a powerful magnetic field. It is able to provide contrast between soft tissues within the body such as the brain, heart, muscles, and cancers. Unlike the CT scan, an MRI uses no radiation.

The Biograph is the first device to allow for simultaneous testing by both machines, according to the , and was given approval based on bench tests which compared the new device with older PET/CT device combinations. The MRI has the ability to provide much more detailed images than the CT and this new combination will allow for a reduction in radiation exposure by a patient.

The new system will allow for much quicker diagnostic testing. Siemens claims that the new system can scan the entire body in as little as 30 minutes. Having the same scans run sequentially could take an hour or more, provided they were both available right after the other. In many cases, patients would be required to wait in between testing for the other machine to become available. This simultaneous testing eliminates that possible wait time.

Siemens Medical Solutions, a division of , is a German engineering company that is headquartered in Pennsylvania. Earlier this year, they unveiled plans to restructure and reorganize their healthcare business in order to improve growth.

© 2010 PhysOrg.com

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts
  • A question about drug tolerance
    created23 hours ago
  • Poor nutrition leading to overeating?
    createdMay 23, 2012
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Brentuximab vedotin effective in large-cell lymphoma

(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...

Cancer created 41 minutes ago | popularity not rated yet | comments 0

Childhood cancer scars survivors later in life

Scars left behind by childhood cancer treatments are more than skin-deep. The increased risk of disfigurement and persistent hair loss caused by childhood cancer and treatment are associated with emotional distress and reduced ...

Cancer created 3 hours ago | popularity not rated yet | comments 0

Amino acid consumption associated with how fast cancer cells divide

For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer's metabolic story. Researchers from ...

Cancer created 3 hours ago | popularity 5 / 5 (1) | comments 1 | with audio podcast

Marked for destruction: Newly developed compound triggers cancer cell death

The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis. Cells are pressured toward apoptosis by expression of pro-apoptotic ...

Cancer created 6 hours ago | popularity 5 / 5 (1) | comments 0

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.

Cancer created 6 hours ago | popularity 4.6 / 5 (18) | comments 1 | with audio podcast


'Personality genes' may help account for longevity

"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage ...

Study provides compelling evidence for an effective new treatment for tinnitus

According to new research, a multidisciplinary approach to treating tinnitus that combines cognitive behaviour therapy with sound-based tinnitus retraining therapy is significantly more effective than currently available ...

Autism often not diagnosed until age 5 or older: U.S. report

(HealthDay) -- Even though autism symptoms typically emerge before age 3, most children with autism are diagnosed when they're 5 or older, a new snapshot of autism in America shows.

Doctors report rise in kids eating detergent packs

(AP) -- Miniature laundry detergent packets arrived on store shelves in recent months as an alternative to bulky bottles and messy spills. But doctors across the country say children are confusing the tiny, brightly colored ...

Gene discovery points towards non-hormonal male contraceptive

A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.

Cyber exercise partners help you go the distance: Motivation gains can double

A new study testing the benefits of a virtual exercise partner shows the presence of a moderately more capable cycling partner can significantly boost the motivation – by as much as 100 percent – ...